- Home
- RVPH vs IROH Comparison
RVPH vs IROH Comparison
Compare RVPH & IROH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- IROH
- Stock Information
- Founded
- RVPH 2006
- IROH 2021
- Country
- RVPH United States
- IROH United States
- Employees
- RVPH N/A
- IROH N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- IROH
- Sector
- RVPH Health Care
- IROH
- Exchange
- RVPH Nasdaq
- IROH Nasdaq
- Market Cap
- RVPH 88.0M
- IROH 91.2M
- IPO Year
- RVPH N/A
- IROH 2023
- Fundamental
- Price
- RVPH $1.87
- IROH $10.39
- Analyst Decision
- RVPH Strong Buy
- IROH
- Analyst Count
- RVPH 5
- IROH 0
- Target Price
- RVPH $11.40
- IROH N/A
- AVG Volume (30 Days)
- RVPH 1.5M
- IROH 34.7K
- Earning Date
- RVPH 11-14-2024
- IROH 01-01-0001
- Dividend Yield
- RVPH N/A
- IROH N/A
- EPS Growth
- RVPH N/A
- IROH N/A
- EPS
- RVPH N/A
- IROH 0.20
- Revenue
- RVPH N/A
- IROH N/A
- Revenue This Year
- RVPH N/A
- IROH N/A
- Revenue Next Year
- RVPH N/A
- IROH N/A
- P/E Ratio
- RVPH N/A
- IROH $53.04
- Revenue Growth
- RVPH N/A
- IROH N/A
- 52 Week Low
- RVPH $0.60
- IROH $9.97
- 52 Week High
- RVPH $4.72
- IROH $11.11
- Technical
- Relative Strength Index (RSI)
- RVPH 48.62
- IROH N/A
- Support Level
- RVPH $1.97
- IROH N/A
- Resistance Level
- RVPH $2.14
- IROH N/A
- Average True Range (ATR)
- RVPH 0.16
- IROH 0.00
- MACD
- RVPH -0.01
- IROH 0.00
- Stochastic Oscillator
- RVPH 40.43
- IROH 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About IROH Iron Horse Acquisitions Corp. Common Stock
Iron Horse Acquisitions Corp is a blank check company.